Ultima Pharmaceuticals Steroids

TIRZEPATIDE - A-TECH LABS

1 vial x 10 mg + 1 amp sterilized water

What is Tirzepatide?
Tirzepatide is an innovative peptide therapy that functions as a dual agonist of both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Originally developed for type 2 diabetes management, it is also recognized for its effectiveness in weight loss and overall metabolic improvement.

Mechanism of Action
By stimulating GIP and GLP-1 receptors, Tirzepatide increases insulin secretion, reduces glucagon release, and slows gastric emptying. This leads to improved glycemic control, appetite suppression, and reduced caloric intake, supporting fat loss and better metabolic health.

Key Benefits
• Blood Sugar Regulation: Improves glycemic control in individuals with type 2 diabetes
• Weight Management: Suppresses appetite and supports sustainable weight loss
• Insulin Sensitivity: Enhances the body’s response to insulin, improving energy utilization
• Cardiovascular Support: May lower the risk of cardiovascular complications in diabetic patients

Possible Side Effects
• Gastrointestinal disturbances such as nausea, diarrhea, or vomiting
• Injection site reactions like redness, itching, or swelling
• Risk of hypoglycemia when combined with other glucose-lowering therapies

Usage Guidelines
• Dosage: Should be prescribed and tailored by a healthcare professional based on individual health goals and conditions
• Administration: Typically injected subcutaneously, following professional guidance
• Post-Use Monitoring: Regular blood glucose and overall health monitoring are recommended

Storage
Refrigerate between 2°C and 8°C (36°F–46°F). Keep away from direct light and do not freeze.

Precautions
• Not suitable for individuals with a history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2
• Should only be used under medical supervision with regular monitoring